Mettler-Toledo International, Inc. $MTD Shares Sold by Pensionfund Sabic

Key Points

• Pensionfund Sabic reduced its stakes in Mettler-Toledo International by 21.7%, ending the first quarter with 900 shares valued at approximately $1,063,000 after selling 250 shares.
• There has been significant activity among large investors, with Voya Investment Management increasing its holdings by 74.7% to own 81,094 shares valued at $95,764,000.
• Mettler-Toledo International's stock has a current average rating of "Moderate Buy" from analysts, with a consensus target price of $1,311.11 despite a recent stock decline of 1.9%.

Pensionfund Sabic cut its stake in shares of Mettler-Toledo International, Inc. (NYSE:MTD - Free Report) by 21.7% during the first quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The firm owned 900 shares of the medical instruments supplier's stock after selling 250 shares during the quarter. Pensionfund Sabic's holdings in Mettler-Toledo International were worth $1,063,000 at the end of the most recent quarter.

Several other hedge funds and other institutional investors have also recently made changes to their positions in the stock. GAMMA Investing LLC grew its position in Mettler-Toledo International by 131,246.3% during the first quarter. GAMMA Investing LLC now owns 386,158 shares of the medical instruments supplier's stock worth $456,018,000 after buying an additional 385,864 shares during the period. Alliancebernstein L.P. grew its holdings in shares of Mettler-Toledo International by 21.6% in the 1st quarter. Alliancebernstein L.P. now owns 709,328 shares of the medical instruments supplier's stock worth $837,653,000 after acquiring an additional 126,147 shares during the period. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC increased its stake in Mettler-Toledo International by 42.0% in the 1st quarter. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC now owns 305,722 shares of the medical instruments supplier's stock valued at $361,030,000 after purchasing an additional 90,395 shares in the last quarter. Nuveen LLC purchased a new position in Mettler-Toledo International in the 1st quarter valued at approximately $71,897,000. Finally, Jones Financial Companies Lllp boosted its position in Mettler-Toledo International by 27,938.9% during the first quarter. Jones Financial Companies Lllp now owns 49,068 shares of the medical instruments supplier's stock worth $57,945,000 after purchasing an additional 48,893 shares in the last quarter. Institutional investors and hedge funds own 95.07% of the company's stock.

Mettler-Toledo International Stock Up 1.3%

Shares of NYSE MTD traded up $16.66 during trading on Tuesday, hitting $1,276.79. 124,222 shares of the company traded hands, compared to its average volume of 117,195. The firm has a market capitalization of $26.30 billion, a P/E ratio of 32.33, a P/E/G ratio of 3.78 and a beta of 1.37. The company has a 50-day moving average price of $1,261.83 and a 200-day moving average price of $1,185.40. Mettler-Toledo International, Inc. has a 1 year low of $946.69 and a 1 year high of $1,521.01.

Mettler-Toledo International (NYSE:MTD - Get Free Report) last issued its earnings results on Thursday, July 31st. The medical instruments supplier reported $10.09 earnings per share for the quarter, beating analysts' consensus estimates of $9.58 by $0.51. Mettler-Toledo International had a negative return on equity of 476.07% and a net margin of 21.46%.The firm had revenue of $983.22 million for the quarter, compared to analysts' expectations of $957.41 million. During the same quarter last year, the firm earned $9.65 earnings per share. The firm's revenue for the quarter was up 3.9% compared to the same quarter last year. Mettler-Toledo International has set its FY 2025 guidance at 42.100-42.600 EPS. Q3 2025 guidance at 10.550-10.750 EPS. Research analysts predict that Mettler-Toledo International, Inc. will post 42.71 EPS for the current fiscal year.

Insider Buying and Selling

In other news, CFO Shawn Vadala sold 300 shares of the firm's stock in a transaction on Tuesday, August 19th. The shares were sold at an average price of $1,325.00, for a total value of $397,500.00. Following the transaction, the chief financial officer owned 5,095 shares of the company's stock, valued at approximately $6,750,875. This trade represents a 5.56% decrease in their position. The sale was disclosed in a legal filing with the SEC, which is available at this link. Also, Director Thomas P. Salice sold 1,062 shares of Mettler-Toledo International stock in a transaction on Wednesday, August 13th. The shares were sold at an average price of $1,300.90, for a total transaction of $1,381,555.80. Following the transaction, the director owned 283 shares in the company, valued at $368,154.70. The trade was a 78.96% decrease in their position. The disclosure for this sale can be found here. In the last quarter, insiders sold 1,827 shares of company stock valued at $2,371,208. 0.77% of the stock is currently owned by corporate insiders.

Analyst Ratings Changes

A number of brokerages have recently weighed in on MTD. Barclays began coverage on Mettler-Toledo International in a research report on Tuesday, June 24th. They issued an "overweight" rating and a $1,325.00 price target for the company. Evercore ISI reduced their price target on shares of Mettler-Toledo International from $1,280.00 to $1,275.00 and set an "outperform" rating on the stock in a report on Monday, August 4th. UBS Group upgraded shares of Mettler-Toledo International from a "neutral" rating to a "buy" rating and lowered their price target for the company from $1,530.00 to $1,350.00 in a research report on Tuesday, May 20th. Robert W. Baird lifted their price objective on Mettler-Toledo International from $1,210.00 to $1,230.00 and gave the stock a "neutral" rating in a research report on Monday, August 4th. Finally, Citigroup increased their target price on Mettler-Toledo International from $1,400.00 to $1,600.00 and gave the company a "buy" rating in a report on Thursday, August 21st. Five analysts have rated the stock with a Buy rating and five have assigned a Hold rating to the stock. According to MarketBeat.com, the stock currently has an average rating of "Moderate Buy" and a consensus target price of $1,311.11.

Mettler-Toledo International Profile

Mettler-Toledo International Inc manufactures and supplies precision instruments and services in the Americas, Europe, Asia, and internationally. It operates through five segments: U.S. Operations, Swiss Operations, Western European Operations, Chinese Operations, and Other. The company's laboratory instruments include laboratory balances, liquid pipetting solutions, automated laboratory reactors, real-time analytics, titrators, pH meters, process analytics sensors and analyzer technologies, physical value analyzers, density and refractometry, thermal analysis systems, and other analytical instruments; and LabX, a laboratory software platform to manage and analyze data generated from its instruments.